Dermatology Times, September 2023 (Vol. 44. No. 09)

Learn more about the in-depth topics covered in the September 2023 print issue of Dermatology Times.

Mature minor statutes exist in most jurisdictions, but courts struggle with balancing the wishes of the adolescent with the need to show they fit into one of the exceptions to the general rule.

Experts explain tactics that should be employed during the “retirement red zone” to allow for a financially successful retirement.

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.

A patient’s journey toward weight loss for overall better health involves multifaceted considerations that extend beyond the numbers on a scale when it comes to sagging or excess skin.

Research has shown that biosimilars are highly similar to their originator product in terms of safety and efficacy.

Peter Lio, MD, offers perspectives on topical steroid withdrawal, also known as red skin syndrome or topical steroid addiction.

There may be delays in diagnosis and treatment of psoriasis in patients with darker skin tones due to the clinical presentation variations and less visible erythema.

Mona Shahriari, MD, introduces "Psoriasis Gaps in Care," a special section of the Dermatology Times September print issue dedicated to skin of color research in psoriasis.

Clinicians can use culturally competent care to ease patients’ concerns with identity and better understand the emotional toll of the condition.

The study is the only large-scale dermatologic study to prospectively generate insights into skin conditions among patients of racial and ethnic minority groups.

With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eye to give patients the natural-looking results they desire.

Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis provides an opportunity for clinicians to share knowledge and research.

Websites and educational materials are available to support clinicians in treating their patients with skin of color.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, describes peptides and their use in skin care.

Treatments using lasers and microneedling for acne and acne scarring have grown in recent years, offering patients more options.

To further discuss the changing landscape of skin of color representation in dermatology, Christopher Bunick, MD, PhD, and Shawn Kwatra, MD, review how they have seen representation change in their own experiences.

In this month's letter from the Editor in Chief, Zoe Diana Draelos, MD, explains why aging is a culmination of disease processes and that more steps should be taken to address aging.

Discover how we continue to spotlight innovation and remain curious with the goal to help you improve patient outcomes.

Rescue workers had a higher rate of malignant melanoma between 2005 and 2015 compared the general population of New York State.

As deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.

This week’s collection of the latest dermatologic studies covers PPT5α for androgenetic alopecia, fractional ablative CO2 laser and concurrent isotretinoin treatment for acne scars, vitamin D insufficiency and 25-hydroxy vitamin D levels related to cutaneous melanoma, and a literature review of baricitinib for alopecia areata.

Collaboration between dermatologists and gynecologists can improve patient quality of life and outcomes in vSCC treatment.

This week’s collection of the latest dermatologic studies covers distinguishing between granular cell tumors and melanoma, methotrexate and biologics for anxiety and depression among PsO patients, botulinum toxin for scalp conditions, and a review of the SPRING study for guselkumab.

Researchers found that use of personal protective equipment could be associated with skin problems; however, protective applications reduced these skin-related problems.

Both companies are hoping to make a positive impact in the neoadjuvant setting of cutaneous squamous cell carcinoma.

Furthermore, a survey showed that more than half of providers do not discuss clothing modifications, and half report providing patients with wound care supplies that are covered by insurance.

Pediatricians are often the first to diagnose and manage pediatric atopic dermatitis, and Larry Eichenfield, MD, led a team to develop a tool to help them.